Answers are grounded in this paper and cite their sources.
Combination therapy improves outcomes in triple negative breast cancer, indicating a novel approach using nanoparticles.
HA–ANI self-assembles into nanoparticles co-loading PTX and IR780. CD44-mediated uptake and high NADPH trigger drug release. NIR laser activates IR780, enabling chemotherapy and phototherapy synergistic TNBC therapy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: